United States

CEU 2023

Fracture Risk and the Management of Denosumab Discontinuation

technical paper

CEU was conducted by renowned endocrinologists and experts for over a decade. This program features a comprehensive, case-based agenda to help you gain knowledge that you can immediately apply to your practice, delivered in an intimate setting where you have access to experts in hormone health.

Update on Various Modalities of Testosterone Replacement

Hypercalcemia of Malignancy – Etiology and Approach to Management

Optimization of Skeletal Health in the Perioperative Setting

Using Diabetes Technology in Patients with Type 2 Diabetes

Pituitary Implications for Childhood Cancer Survivors

Management of Thyroid Eye Disease

Pituitary Dysfunction and Quality of Life - Quality of Life, Brain Fog and Pituitary Tumors

Thyroid Nodule Management - Thyroid Nodules 2023: Where We Are and Where We Are Headed

Medullary Thyroid Carcinoma

Update in Thyroid Cytology and Pathology

https://d3smihljt9218e.cloudfront.net/transcript/59262/subtitle/dc87c47f5f08656ba4669bc98d230ed4.vtt

English (automatic)

Premium content

Fracture Risk and the Management of Denosumab Discontinuation

Downloads

Next from CEU 2023

Update on Various Modalities of Testosterone Replacement

Stay up to date with the latest Underline news!

PRESENTATIONS

CONFERENCES

COMPANY

RESOURCES